Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies

The use and interpretation of diagnostic cerebrospinal fluid (CSF) biomarkers for neurodegenerative disorders, such as Dementia with Lewy bodies (DLB), represent a clinical challenge. According to the literature, the composition of CSF in DLB patients varies. Some patients present with reduced level...

Descripción completa

Detalles Bibliográficos
Autores principales: Foska, Aikaterini, Tsantzali, Ioanna, Sideri, Eleni, Stefanou, Maria Ioanna, Bakola, Eleni, Kitsos, Dimitrios K., Zompola, Christina, Bonakis, Anastasios, Giannopoulos, Sotirios, Voumvourakis, Konstantinos I., Tsivgoulis, Georgios, Paraskevas, George P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144333/
https://www.ncbi.nlm.nih.gov/pubmed/35630029
http://dx.doi.org/10.3390/medicina58050612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144333/
https://www.ncbi.nlm.nih.gov/pubmed/35630029
http://dx.doi.org/10.3390/medicina58050612

Ejemplares similares